Dash Bio is a preclinical and clinical bioanalysis company that leverages a fully automated bioanalysis platform to enhance the speed, precision, and scalability of drug development. The company focuses on transforming the drug development process through innovative tech-enabled services, aiming to streamline and accelerate bioanalytical workflows.
Leadership & Board
Key Executives
FounderDave Johnson
FounderAnder Tallett
FounderEly Porter
Current Number of Employees43
Current LinkedIn Followers8,089
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$48M
Total Amount Raised$48M
Total Funding Rounds3
Total Funding Rounds3
Latest Funding Amount$30M
Latest Funding Amount$30M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Dash Bio had 43 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
43Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Dash Bio had 8,089 followers as of September 7, 2026. The number of followers increased by 50 (0.62%) week-over-week.
8,089Latest Followers Count
50(0.62%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.